Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis
Read Article
News
2024
2023
Archive
Search news articles
April 14, 2010
SYNOSIA THERAPEUTICS’ SYN-115 IMPROVES MOTOR AND NON-MOTOR FUNCTION IN PATIENTS WITH MILD-TO-MODERATE PARKINSON’S DISEASE
April 7, 2010
ACHAOGEN COMPLETES $56 MILLION SERIES C FINANCING
March 30, 2010
IKARIA® ACQUIRES NEW DRUG APPLICATION FOR LUCASSIN®
March 29, 2010
PEARL THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM PHASE 1 TRIAL OF PT003, A BRONCHODILATOR COMBINATION THERAPEUTIC FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AND INITIATION OF PHASE 2B TRIAL
February 17, 2010
MARCADIA INITIATES PHASE I CLINICAL TRIAL OF GLP-1/GIP DUAL AGONIST MAR701
February 1, 2010
SYNOSIA ANNOUNCES POSITIVE INTERIM RESULTS FOR POTENTIAL FIRST-IN-CLASS TREATMENT FOR PARKINSON’S DISEASE
February 1, 2010
PEARL THERAPEUTICS RAISES $15 MILLION TO ADVANCE PT003, LAMA/LABA COMBINATION BRONCHODILATOR FOR COPD, INTO PHASE 2B STUDY
January 29, 2010
FLEXION THERAPEUTICS ANNOUNCES AGREEMENTS WITH FOUR MAJOR PHARMACEUTICAL COMPANIES
January 26, 2010
ENVOY ENTERS DIABETES AND OBESITY COLLABORATION WITH MERCK & CO., INC.
January 4, 2010
PEARL THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM PHASE 2A TRIAL OF FORMOTEROL INHALATION AEROSOL IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
« Previous Page
1
…
114
115
116
117
118
119
Next Page »